Pharming Group N.V. ADR
(PHAR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 74,100 | 55,586 | 81,214 | 66,661 | 54,900 |
| Cost of Goods | 8,000 | 8,386 | 7,142 | 8,295 | 5,700 |
| Gross Profit | 66,100 | 47,200 | 74,072 | 58,366 | 49,200 |
| Operating Expenses | 69,200 | 63,898 | 73,146 | 56,753 | 44,600 |
| Operating Income | -3,100 | -16,312 | 1,068 | 1,908 | 5,300 |
| Other Income | 3,000 | -312 | -3,113 | 1,399 | -1,900 |
| Pre-tax Income | -100 | -16,624 | -2,045 | 3,307 | 3,400 |
| Income Tax | 1,100 | -4,176 | 1,059 | -157 | 2,100 |
| Net Income Continuous | -1,200 | -12,448 | -3,104 | 3,464 | 1,300 |
| Net Income | $-1,200 | $-12,448 | $-3,104 | $3,464 | $1,300 |
| EPS Basic Total Ops | -0.02 | -0.19 | N/A | 0.05 | -0.02 |
| EPS Basic Continuous Ops | -0.02 | -0.19 | 0.00 | 0.05 | -0.02 |
| EPS Diluted Total Ops | -0.02 | -0.19 | N/A | 0.05 | -0.02 |
| EPS Diluted Continuous Ops | -0.02 | -0.19 | 0.01 | 0.05 | -0.02 |
| EPS Diluted Before Non-Recurring Items | -0.01 | -0.19 | -0.03 | N/A | N/A |
| EBITDA(a) | $-3,393 | $-10,391 | $8,623 | $4,810 | $8,462 |